BIOTON S.A.

Warsaw Stock Exchange:BIO.WA

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

🔬 Clinical Trials

💊 Drugstores & Retail Pharmacies

Location

Poland

Market Cap

USD 97.22 M

Share Price

USD 1.13

Avg Daily Volume

51,461

Change (1 day)

3.15%

Change (1 year)

32.10%

Change (YTD)

61.29%

BIOTON S.A. Share Price Year-To-Date (YTD) return on June 20, 2025: 61.29%

BIOTON S.A. Share Price Year-To-Date (YTD) return is 61.29% on June 20, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.

BIOTON S.A. 52-week low Share Price is USD 1.14 on June 20, 2025, which is 0.37% above the current Share Price.
BIOTON S.A. 52-week low Share Price is USD 0.68 on June 20, 2025, which is -39.75% below the current Share Price.
BIOTON S.A. average Share Price for the last 52 weeks is USD 0.90.

Daily

From:

To:

Zoom:

Key data

Date	Share Price Year-To-Date (YTD) return	Price to Earnings Ratio (P/E)	Price to Book Ratio (P/B)	Price to Sales Ratio (P/S)

Warsaw Stock Exchange: BIO.WA

BIOTON S.A.

CEO	Mr. Jeremy Launders
IPO Date	March 31, 2005
Location	Poland
Headquarters	ul. Poznanska 12
Employees	361
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology 🔬 Clinical Trials 💊 Drugstores & Retail Pharmacies

Description

BIOTON S.A., a biotechnology company, develops, manufactures, markets, and sells pharmaceuticals, pharmaceutical preparations, pharmaceutical substances, medications, and other pharmaceutical products in Poland, China, Thailand, Vietnam, Libya, Argentina, Ukraine, Malta, Yemen, and the Russian Federation. The company offers recombinant human and classic insulin; oral anti-diabetic medication products; dietary supplements; strips for measuring sugar in blood, as well as OTC preparation for diabetics; diabetics drugs insulin vials and cartridges, including Gensulin N, Gensulin R, and Gensulin M30; GensuPen 2, an automatic injection system; and GensuCare glucometer, a diabetes monitoring technology, as well as needles. It engages in advertising, advisory, and company management activities. The company was founded in 1989 and is based in Ozarów Mazowiecki, Poland.